 May.11 -- Ginkgo Bioworks Inc., which calls itself an organism design company, has agreed to go public in a 17.5 billion merger with a blank-check firm backed by former Hollywood executive Harry Sloan. Ginkgo CEO Jason Kelly speaks to Emily Chang and Matt Miller. 